Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11082126rdf:typepubmed:Citationlld:pubmed
pubmed-article:11082126lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:11082126lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:11082126lifeskim:mentionsumls-concept:C0014257lld:lifeskim
pubmed-article:11082126lifeskim:mentionsumls-concept:C0003483lld:lifeskim
pubmed-article:11082126lifeskim:mentionsumls-concept:C0025465lld:lifeskim
pubmed-article:11082126lifeskim:mentionsumls-concept:C0074554lld:lifeskim
pubmed-article:11082126lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:11082126lifeskim:mentionsumls-concept:C1521761lld:lifeskim
pubmed-article:11082126lifeskim:mentionsumls-concept:C1314939lld:lifeskim
pubmed-article:11082126lifeskim:mentionsumls-concept:C1880022lld:lifeskim
pubmed-article:11082126pubmed:issue6lld:pubmed
pubmed-article:11082126pubmed:dateCreated2001-2-2lld:pubmed
pubmed-article:11082126pubmed:abstractText1. Vascular effects of the 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor, simvastatin, were studied in conductance (aorta) and resistance vessels (branch II or III of superior mesenteric artery, SMA) of the rat (12 - 14 weeks old). 2. Simvastatin produced relaxation of both aorta and SMA, with and without functional endothelium. These responses were inhibited by the product of HMG-CoA reductase, mevalonate (1 mmol l(-1)). 3. In vessels with functional endothelium, the NO-synthase inhibitor, L-N(G)-nitroarginine (L-NOARG, 30 micromol l(-1)), inhibited simvastatin-induced relaxation. In the presence of L-NOARG, relaxation to simvastatin was lower in vessels with endothelium than in endothelium-denuded arteries without L-NOARG. 4. The cyclo-oxygenase inhibitor, indomethacin (10 micromol l(-1)), abolished endothelium-dependent component of the response to simvastatin in both arteries. The combination of L-NOARG plus indomethacin did not produce further inhibition. The T(p) receptor antagonist, GR 32191B (3 micromol l(-1)), did not affect relaxation in aorta but it reduced response to low concentrations of simvastatin in SMA. However, the inhibitory effect of L-NOARG was less marked in the presence of GR 32191B in aorta but not in SMA. 5. The endothelium-dependent relaxation to simvastatin was inhibited by the superoxide dismutase (SOD, 100 u ml(-1)) or by the tyrosine kinase inhibitor, genistein (30 micromol l(-1)) in the two arteries. 6. The present study shows that simvastatin produces relaxation of conductance and small arteries through mevalonate-sensitive pathway. The endothelium-dependent relaxation to simvastatin involves both NO and vasodilator eicosanoids by a mechanism sensitive to SOD, and to genistein. Also, the results highlighted participation in the aorta of endothelial vasoconstrictor eicosanoids acting on the T(p) receptor after blockage of NO synthase only.lld:pubmed
pubmed-article:11082126pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11082126pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11082126pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11082126pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11082126pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11082126pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11082126pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11082126pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11082126pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11082126pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11082126pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11082126pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11082126pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11082126pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11082126pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11082126pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11082126pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11082126pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11082126pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11082126pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11082126pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11082126pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11082126pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11082126pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11082126pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11082126pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11082126pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11082126pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11082126pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11082126pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11082126pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11082126pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11082126pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11082126pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11082126pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11082126pubmed:languageenglld:pubmed
pubmed-article:11082126pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11082126pubmed:citationSubsetIMlld:pubmed
pubmed-article:11082126pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11082126pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11082126pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11082126pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11082126pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11082126pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11082126pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11082126pubmed:statusMEDLINElld:pubmed
pubmed-article:11082126pubmed:monthNovlld:pubmed
pubmed-article:11082126pubmed:issn0007-1188lld:pubmed
pubmed-article:11082126pubmed:authorpubmed-author:MarhuendaEElld:pubmed
pubmed-article:11082126pubmed:authorpubmed-author:HerreraM DMDlld:pubmed
pubmed-article:11082126pubmed:authorpubmed-author:Andriantsitoh...lld:pubmed
pubmed-article:11082126pubmed:authorpubmed-author:Alvarez De...lld:pubmed
pubmed-article:11082126pubmed:issnTypePrintlld:pubmed
pubmed-article:11082126pubmed:volume131lld:pubmed
pubmed-article:11082126pubmed:ownerNLMlld:pubmed
pubmed-article:11082126pubmed:authorsCompleteYlld:pubmed
pubmed-article:11082126pubmed:pagination1179-87lld:pubmed
pubmed-article:11082126pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:11082126pubmed:meshHeadingpubmed-meshheading:11082126...lld:pubmed
pubmed-article:11082126pubmed:meshHeadingpubmed-meshheading:11082126...lld:pubmed
pubmed-article:11082126pubmed:meshHeadingpubmed-meshheading:11082126...lld:pubmed
pubmed-article:11082126pubmed:meshHeadingpubmed-meshheading:11082126...lld:pubmed
pubmed-article:11082126pubmed:meshHeadingpubmed-meshheading:11082126...lld:pubmed
pubmed-article:11082126pubmed:meshHeadingpubmed-meshheading:11082126...lld:pubmed
pubmed-article:11082126pubmed:meshHeadingpubmed-meshheading:11082126...lld:pubmed
pubmed-article:11082126pubmed:meshHeadingpubmed-meshheading:11082126...lld:pubmed
pubmed-article:11082126pubmed:meshHeadingpubmed-meshheading:11082126...lld:pubmed
pubmed-article:11082126pubmed:meshHeadingpubmed-meshheading:11082126...lld:pubmed
pubmed-article:11082126pubmed:meshHeadingpubmed-meshheading:11082126...lld:pubmed
pubmed-article:11082126pubmed:meshHeadingpubmed-meshheading:11082126...lld:pubmed
pubmed-article:11082126pubmed:meshHeadingpubmed-meshheading:11082126...lld:pubmed
pubmed-article:11082126pubmed:meshHeadingpubmed-meshheading:11082126...lld:pubmed
pubmed-article:11082126pubmed:meshHeadingpubmed-meshheading:11082126...lld:pubmed
pubmed-article:11082126pubmed:year2000lld:pubmed
pubmed-article:11082126pubmed:articleTitleCharacterization of endothelial factors involved in the vasodilatory effect of simvastatin in aorta and small mesenteric artery of the rat.lld:pubmed
pubmed-article:11082126pubmed:affiliationDepartment of Pharmacology, Faculty of Pharmacy, University of Seville.C/ Profesor Garcia-Gonzalez s/n, 41012 Seville, Spain. aldesoto@fafar.us.eslld:pubmed
pubmed-article:11082126pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11082126lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11082126lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11082126lld:pubmed